NLRP3 and cancer: However, in cancer, this fine balance between NLRP3 activation, inflammation and autophagy might be dysregulated to support cell proliferation, survival and resistance to chemotherapy of malignant cells in an adaptive and context-dependent fashion (Figure 3).